Understand prolactinemia diagnosis, including elevated prolactin levels, causes, symptoms, and treatment. Find information on hyperprolactinemia, prolactin blood test, pituitary adenoma, galactorrhea, amenorrhea, infertility, and medication side effects. Learn about ICD-10 code E22.1 for prolactinemia, medical coding guidelines, clinical documentation improvement, and healthcare resources for patients and professionals.
Also known as
Hyperprolactinemia
Elevated prolactin levels in the blood.
Pituitary disorder, unspecified
Unspecified disorder of the pituitary gland, which can cause prolactinemia.
Other specified disorders of breast
Includes galactorrhea, sometimes caused by hyperprolactinemia.
Other abnormal findings of blood chemistry
Can be used for abnormal prolactin levels if no other cause is found.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the prolactinemia due to a drug or other external agent?
Yes
Code D58.2 Drug-induced hyperprolactinemia
No
Is the prolactinemia associated with pregnancy?
When to use each related code
Description |
---|
High prolactin level |
Drug-induced hyperprolactinemia |
Prolactinoma |
Coding E22.1 without identifying underlying cause (medication, pituitary adenoma) leads to inaccurate reporting and potential DRG misclassification.
Failing to code drug-induced hyperprolactinemia (E22.1, with appropriate external cause code) impacts pharmacovigilance and quality metrics.
Incorrectly coding normal physiological hyperprolactinemia (pregnancy, lactation) as pathological can trigger unnecessary investigations and treatment.
Patient presents with complaints suggestive of prolactinemia, including galactorrhea, amenorrhea, oligomenorrhea, infertility, decreased libido, andor erectile dysfunction. Onset and duration of symptoms were documented. Past medical history, surgical history, family history, and medication history, including the use of dopamine antagonists, antipsychotics, antidepressants, and antihypertensives, were reviewed for potential contributing factors. Physical examination findings were noted, including the presence or absence of galactorrhea and assessment of visual fields. Laboratory results confirmed elevated prolactin levels. Differential diagnoses considered included pituitary adenoma, hypothyroidism, polycystic ovary syndrome, medications, and other causes of hyperprolactinemia. A pregnancy test was performed if applicable. Brain MRI with pituitary protocol was ordered or is planned to evaluate for pituitary adenoma or other structural abnormalities. The patient was counseled on the potential causes of hyperprolactinemia, treatment options, and the importance of follow-up. Initial management may include dopamine agonist therapy such as cabergoline or bromocriptine, with dosage and frequency documented. Patient education regarding medication side effects, monitoring, and potential complications was provided. Follow-up appointments were scheduled to monitor prolactin levels, assess treatment response, and adjust management as needed. ICD-10 code E22.1 (Hyperprolactinemia) is documented for billing and coding purposes. CPT codes for laboratory tests, imaging studies, and office visits are documented as appropriate.